These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

160 related items for PubMed ID: 37566742

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. LncRNA-H19 promotes hepatic lipogenesis by directly regulating miR-130a/PPARγ axis in non-alcoholic fatty liver disease.
    Liu J, Tang T, Wang GD, Liu B.
    Biosci Rep; 2019 Jul 31; 39(7):. PubMed ID: 31064820
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. LncRNA HOTAIR regulates the lipid accumulation in non-alcoholic fatty liver disease via miR-130b-3p/ROCK1 axis.
    Guo B, Cheng Y, Yao L, Zhang J, Lu J, Qi H, Chen H.
    Cell Signal; 2022 Feb 31; 90():110190. PubMed ID: 34774989
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. LncRNA NEAT1 in the pathogenesis of liver-related diseases.
    Saleh RO, Alkhafaji AT, Mohammed JS, Bansal P, Kaur H, Ahmad I, Hjazi A, Mohammed IH, Jawad MA, Zwamel AH.
    Cell Biochem Funct; 2024 Apr 31; 42(3):e4006. PubMed ID: 38622913
    [Abstract] [Full Text] [Related]

  • 15. LncRNA NEAT1 facilitates survival and angiogenesis in oxygen-glucose deprivation (OGD)-induced brain microvascular endothelial cells (BMECs) via targeting miR-377 and upregulating SIRT1, VEGFA, and BCL-XL.
    Zhou ZW, Zheng LJ, Ren X, Li AP, Zhou WS.
    Brain Res; 2019 Mar 15; 1707():90-98. PubMed ID: 30408478
    [Abstract] [Full Text] [Related]

  • 16. Long non-coding RNA (lncRNA) H19 induces hepatic steatosis through activating MLXIPL and mTORC1 networks in hepatocytes.
    Wang H, Cao Y, Shu L, Zhu Y, Peng Q, Ran L, Wu J, Luo Y, Zuo G, Luo J, Zhou L, Shi Q, Weng Y, Huang A, He TC, Fan J.
    J Cell Mol Med; 2020 Jan 15; 24(2):1399-1412. PubMed ID: 31809000
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Long noncoding RNA lncARSR promotes nonalcoholic fatty liver disease and hepatocellular carcinoma by promoting YAP1 and activating the IRS2/AKT pathway.
    Chi Y, Gong Z, Xin H, Wang Z, Liu Z.
    J Transl Med; 2020 Mar 13; 18(1):126. PubMed ID: 32169080
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Long noncoding RNA FLRL2 alleviated nonalcoholic fatty liver disease through Arntl-Sirt1 pathway.
    Chen Y, Chen X, Gao J, Xu C, Xu P, Li Y, Zhu Y, Yu C.
    FASEB J; 2019 Oct 13; 33(10):11411-11419. PubMed ID: 31311301
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 8.